The announcement on January 5th of the acquisition of Redvax, spin-off of Redbiotec, by Pfizer was covered by a large number of news outlets worldwide, including Financial Times, Walls Street Journal, Nasdaq, NZZ.

Redbiotec would like to thank for the positive global feedback from CMV experts, life science investors, business developers, financial advisors and entrepreneurs we received last week.

Please also read Redbiotec press release.